New Data on Vimpat® (lacosamide) C-V to be Presented at the 64th Annual Meeting of the American Epilepsy Society
New data on UCB's anti-epileptic drug Vimpat® C-V will be presented at the 64th annual meeting of the American Epilepsy Society , taking place at the San Antonio Convention Center in San Antonio, Texas from December 3 to 7.  Data will also be presented on Keppra XR and the investigative epilepsy therapy, brivaracetam.
Read more on PR Newswire via Yahoo!
No comments:
Post a Comment